Press Releases GB Sciences, Inc.

Equities

GBLX

US3615441090

Delayed OTC Markets Other stock markets 01:02:12 2024-05-07 pm EDT			5-day change	1st Jan Change
0.0073 ^USD	-10.98%		+12.31%	+14.06%

Feb. 12	GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)	23-04-14	AQ
GB SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)	23-03-10	AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-03	AQ
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22	GL
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22	GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	22-12-12	GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	22-12-12	AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-09	AQ
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients	22-11-01	AQ
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit	22-10-27	AQ
Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study	22-10-24	AQ
TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference	22-10-13	AQ
Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease	22-10-10	AQ
TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article	22-09-06	AQ
GB SCIENCES INC : Unregistered Sale of Equity Securities (form 8-K)	22-08-30	AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-11	AQ
Gb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™	22-07-18	GL
Gb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™	22-07-18	AQ
GB SCIENCES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	22-06-30	AQ
TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit	22-05-23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GB Sciences, Inc.

Equities

GBLX

US3615441090

Press Releases

Filters